Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/VIFOR-PHARMA-35018535/news/Vifor-meldet-positive-Ergebnisse-in-Phase-I-Studie-fur-Ferroportin-Inhibitor-27830146/?utm_source=whatsapp&utm_medium=social&utm_campaign=share